Robin John is co-founder and Chief Executive Officer of Eventide. He is responsible for the overall leadership of the organization, and under his leadership, the firm has grown into a leader within values based investing.
Prior to Eventide, Mr. John held leadership roles for Bank of New York Mellon. He has also served as a business consultant for Grant Thornton. He has a degree in Economics from Tufts University.
Finny Kuruvilla, MD, PhD serves as CIO for Eventide Funds and Portfolio Manager for the Eventide Gilead Fund and the Eventide Healthcare & Life Sciences Fund.
Dr. Kuruvilla has a unique background in healthcare, statistics, and investing. Concurrent with Eventide, from 2008 through 2016, he was a Principal at Clarus Ventures, a leading healthcare and life sciences venture capital firm. Prior to joining Eventide, from 2005-2008, he was a postdoctoral research scientist in medical genetics at the Broad Institute of Harvard and MIT. From 2003-2007, he was resident, chief resident, and clinical fellow at the Brigham and Women’s Hospital and Children’s Hospital Boston.
Dr. Kuruvilla holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree in Chemistry from Caltech.
Jason Myhre serves as Director of Advocacy at Eventide. In this capacity, he serves as an advocate for “investing that makes the world rejoice”® and the Business 360 investing philosophy to investor, business, and popular audiences.
In prior roles at Eventide, Mr. Myhre led Marketing and Sales. Before joining Eventide, he worked in internal sales and managed key customer relationships for Altec.
Mr. Myhre holds a M.S. and a B.S. in Biological Engineering from the University of Florida.
Mutual funds involve risk including the possible loss of principal. Past performance does not guarantee future results. The Funds’ ethical values screening criteria could cause them to under-perform similar funds that do not have such screening criteria.
Investors should consider a fund’s investment objectives, risks, charges and expenses carefully before investing or sending money. This and other important information can be found in the prospectus, which can be obtained at https://www.eventidefunds.com/prospectus or by calling 1-877-771-EVEN (3836). Please read the prospectus carefully before investing. Eventide Mutual Funds are distributed by Northern Lights Distributors, LLC, Member FINRA/SIPC, which is not affiliated with Eventide Asset Management, LLC.